Allianz Asset Management’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-223,605
Closed -$131M 2819
2017
Q4
$131M Sell
223,605
-32,220
-13% -$20.8M 0.1% 237
2017
Q3
$189M Sell
255,825
-5,945
-2% -$4.93M 0.16% 121
2017
Q2
$227M Sell
261,770
-2,975
-1% -$2.49M 0.22% 84
2017
Q1
$225M Buy
264,745
+103,855
+65% +$86.1M 0.22% 78
2016
Q4
$123M Sell
160,890
-75,190
-32% -$56.8M 0.11% 217
2016
Q3
$194M Sell
236,080
-51,750
-18% -$44.7M 0.19% 109
2016
Q2
$240M Sell
287,830
-125
-0% -$104K 0.26% 65
2016
Q1
$265M Sell
287,955
-3,225
-1% -$3.08M 0.3% 64
2015
Q4
$300M Sell
291,180
-2,920
-1% -$2.93M 0.34% 55
2015
Q3
$277M Sell
294,100
-4,000
-1% -$4.17M 0.33% 57
2015
Q2
$312M Buy
+298,100
New +$312M 0.33% 63

Other funds holding AGN.PRA

Allianz Asset Management's AGN.PRA Position: Q1 2018 in Review

Allianz Asset Management sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 223,605 shares — an estimated $131M sold.

Allianz Asset Management first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $312M in Q2 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Allianz Asset Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Allianz Asset Management sold 223,605 Allergan plc shares in Q1 2018, an estimated $131M.
  • Allianz Asset Management first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Allianz Asset Management's Allergan plc position peaked at $312M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Allianz Asset Management's 13F filing for Q1 2018, filed 14 May 2018.